CNS Pharmaceuticals, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:CNSP) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 13.75 M14.51 M11.87 M8.62 M4.65 M Total liabilities 2.78 M1.38 M1.96 M4.1 M4.58 M Total equity 10.97 M13.12 M9.91 M4.52 M70.7 K Total liabilities & shareholders' equities 13.75 M14.51 M11.87 M8.62 M4.65 M Total debt ————— Net debt —————

News

CNS Pharmaceuticals (NASDAQ: CNSP) Highlights Oversubscribed $22.5M Financing, Growth Strategy in Investor Presentation

What's Going On With CNS Pharmaceuticals Stock On Wednesday? - CNS Pharmaceuticals (NASDAQ:CNSP)

CNS Pharmaceuticals shifts focus to neurology, oncology assets

CNS Pharmaceuticals names Lynne Kelley as chief medical officer

CNS Pharmaceuticals appoints three new executives to leadership team

CNS Pharmaceuticals’ new CEO outlines strategic overhaul

Corero Network Security reports DDoS protection platform enhancements

CNS Pharmaceuticals stock falls after CEO steps down

CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco

CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting

CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript

Corero Network Security reports Q3 order intake growth